Based on the pathological characteristics of CHD, several inflammatory biomarkers (e.g., C-reactive protein, fibrinogen, serum amyloid A and interleukin-6) have been proposed for the diagnosis of CHD [8], but none have achieved effective clinical application. Here, IL6 is linked to coronary artery disorder.